PRESS RELEASE published on 01/30/2024 at 16:04, 10 months 22 days ago VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial VenoStent enrolls its first patient into a 200-subject, one-to-one randomized controlled trial (RCT) to improve outcomes from arteriovenous fistula creation surgery, as part of its SAVE-FistulaS Clinical Trial in the US. This trial marks a significant milestone in the development of bioabsorbable wraps for hemodialysis patients VenoStent SAVE-FistulaS Clinical Trial Arteriovenous Fistula Bioabsorbable Wrap Hemodialysis Patients
PRESS RELEASE published on 07/31/2023 at 16:04, 1 year 4 months ago VenoStent Completes $16M Series A Financing, Receives IDE Approval from FDA to Begin US Trial
Published on 12/21/2024 at 01:30, 18 hours 3 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 18 hours 3 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 28 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 20 hours 3 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 18 hours 41 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 48 minutes ago EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 18:00, 1 day 1 hour ago ARYZTA AG Announces New Board Technology Committee
Published on 12/21/2024 at 12:17, 7 hours 15 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days 1 hour ago Share capital decrease by way of treasury shares cancellation
